Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study

od McGarragle, Kaitlin M., Hare, Crystal, Holter, Spring, Facey, Dorian Anglin, McShane, Kelly, Gallinger, Steven, Hart, Tae L.
Izdano u Hered Cancer Clin Pract (2019)

Regulation of Tissue Inhibitor of Metalloproteinase-1 by Astrocytes: Links to HIV-1 Dementia

od SURYADEVARA, RADHIKA, HOLTER, SPRING, BORGMANN, KATHLEEN, PERSIDSKY, RAISA, LABENZ-ZINK, CHRISTINE, PERSIDSKY, YURI, GENDELMAN, HOWARD E., WU, LI, GHORPADE, ANUJA
Izdano 2003

Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome

od McGarragle, Kaitlin M., Aronson, Melyssa, Semotiuk, Kara, Holter, Spring, Hare, Crystal J., Ferguson, Sarah E., Cohen, Zane, Hart, Tae L.
Izdano u Hered Cancer Clin Pract (2019)

Clinicopathologic and genetic features of young patients with colorectal cancer

od Aronson, Melyssa, Gallinger, Steve, Rothenmund, Heidi, Semotiuk, Kara, Holter, Spring, Berk, Terri, Pollett, Aaron, Cohen, Zane, Bapat, Bharati, Kim, Hyeja, Gryfe, Robert
Izdano 2010

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer

od Grant, Robert C., Selander, Iris, Connor, Ashton A., Selvarajah, Shamini, Borgida, Ayelet, Briollais, Laurent, Petersen, Gloria M., Lerner-Ellis, Jordan, Holter, Spring, Gallinger, Steven
Izdano u Gastroenterology (2014)

Disclosing genetic research results: experiences of the Colon Cancer Family Registry

od Keogh, Louise, Fisher, Douglass, Schully, Sheri, Lowery, Jan, Ahnen, Dennis, Maskiell, Judi, Lindor, Noralane, Hopper, John, Burnett, Terrilea, Holter, Spring, Gorin, Sheri Sheinfeld, Sinicrope, Pam
Izdano 2011

Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer

od Tischkowitz, Marc D., Sabbaghian, Nelly, Hamel, Nancy, Borgida, Ayelet, Rosner, Chaim, Taherian, Nassim, Srivastava, Archana, Holter, Spring, Rothenmund, Heidi, Ghadirian, Parviz, Foulkes, William D., Gallinger, Steven
Izdano 2009

Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study

od Golan, Talia, Raitses‐Gurevich, Maria, Kelley, Robin K., Bocobo, Andrea G., Borgida, Ayelet, Shroff, Rachna T., Holter, Spring, Gallinger, Steven, Ahn, Daniel H., Aderka, Dan, Apurva, Jain, Bekaii‐Saab, Tanois, Friedman, Eitan, Javle, Milind
Izdano u Oncologist (2017)

Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer

od Grant, Robert C, Al-Sukhni, Wigdan, Borgida, Ayelet E, Holter, Spring, Kanji, Zaheer S, McPherson, Treasa, Whelan, Emily, Serra, Stefano, Trinh, Quang M, Peltekova, Vanya, Stein, Lincoln D, McPherson, John D, Gallinger, Steven
Izdano 2013

The PREMM(1,2,6) Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer History

od Kastrinos, Fay, Steyerberg, Ewout W., Mercado, Rowena, Balmaña, Judith, Holter, Spring, Gallinger, Steven, Siegmund, Kimberly D., Church, James M., Jenkins, Mark A., Lindor, Noralane M., Thibodeau, Stephen N., Burbidge, Lynn Anne, Wenstrup, Richard J., Syngal, Sapna
Izdano 2010

How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry

od Keogh, Louise A., Fisher, Douglass, Sheinfeld Gorin, Sherri, Schully, Sheri D., Lowery, Jan T., Ahnen, Dennis J., Maskiell, Judith A., Lindor, Noralane M., Hopper, John L., Burnett, Terrilea, Holter, Spring, Arnold, Julie L., Gallinger, Steven, Laurino, Mercy, Esplen, Mary-Jane, Sinicrope, Pamela S.
Izdano 2013

Identification of germline genomic copy number variation in familial pancreatic cancer

od Al-Sukhni, Wigdan, Joe, Sarah, Lionel, Anath C., Zwingerman, Nora, Zogopoulos, George, Marshall, Christian R., Borgida, Ayelet, Holter, Spring, Gropper, Aaron, Moore, Sara, Bondy, Melissa, Klein, Alison P., Petersen, Gloria M., Rabe, Kari G., Schwartz, Ann G., Syngal, Sapna, Scherer, Stephen W., Gallinger, Steven
Izdano 2012

Additional germline findings from a tumor profiling program

od Stjepanovic, Neda, Stockley, Tracy L., Bedard, Philippe L., McCuaig, Jeanna M., Aronson, Melyssa, Holter, Spring, Semotiuk, Kara, Leighl, Natasha B., Jang, Raymond, Krzyzanowska, Monika K., Oza, Amit M., Gupta, Abha, Elser, Christine, Ahmed, Lailah, Wang, Lisa, Kamel-Reid, Suzanne, Siu, Lillian L., Kim, Raymond H.
Izdano u BMC Med Genomics (2018)

Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

od Rumilla, Kandelaria, Schowalter, Karen V., Lindor, Noralane M., Thomas, Brittany C., Mensink, Kara A., Gallinger, Steven, Holter, Spring, Newcomb, Polly A., Potter, John D., Jenkins, Mark A., Hopper, John L., Long, Tiffany I., Weisenberger, Daniel J., Haile, Robert W., Casey, Graham, Laird, Peter W., Le Marchand, Loic, Thibodeau, Stephen N.
Izdano 2011

Candidate DNA Repair Susceptibility Genes Identified by Exome Sequencing in High-Risk Pancreatic Cancer

od Smith, Alyssa L., Alirezaie, Najmeh, Connor, Ashton, Chan-Seng-Yue, Michelle, Grant, Robert, Selander, Iris, Bascuñana, Claire, Borgida, Ayelet, Hall, Anita, Whelan, Thomas, Holter, Spring, McPherson, Treasa, Cleary, Sean, Petersen, Gloria M., Omeroglu, Atilla, Saloustros, Emmanouil, McPherson, John, Stein, Lincoln D., Foulkes, William D., Majewski, Jacek, Gallinger, Steven, Zogopoulos, George
Izdano u Cancer Lett (2015)

A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene

od Wong, Cavin, Chen, Fei, Alirezaie, Najmeh, Wang, Yifan, Cuggia, Adeline, Borgida, Ayelet, Holter, Spring, Lenko, Tatiana, Domecq, Celine, Petersen, Gloria M., Syngal, Sapna, Brand, Randall, Rustgi, Anil K., Cote, Michele L., Stoffel, Elena, Olson, Sara H., Roberts, Nicholas J., Akbari, Mohammad R., Majewski, Jacek, Klein, Alison P., Greenwood, Celia M. T., Gallinger, Steven, Zogopoulos, George
Izdano u PLoS Genet (2019)

Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer

od Kim, Soyoun Rachel, Tone, Alicia, Kim, Raymond H., Cesari, Matthew, Clarke, Blaise A., Eiriksson, Lua, Hart, Tae, Aronson, Melyssa, Holter, Spring, Lytwyn, Alice, Maganti, Manjula, Oldfield, Leslie, Gallinger, Steven, Bernardini, Marcus Q., Oza, Amit M., Djordjevic, Bojana, Lerner‐Ellis, Jordan, Van de Laar, Emily, Vicus, Danielle, Pugh, Trevor J., Pollett, Aaron, Ferguson, Sarah E.
Izdano u Cancer (2020)

PMS2 monoallelic mutation carriers: the known unknown

od Goodenberger, McKinsey L., Thomas, Brittany C., Riegert-Johnson, Douglas, Boland, C. Richard, Plon, Sharon E., Clendenning, Mark, Ko Win, Aung, Senter, Leigha, Lipkin, Steven M., Stadler, Zsofia K., Macrae, Finlay A., Lynch, Henry T., Weitzel, Jeffrey N., de la Chapelle, Albert, Syngal, Sapna, Lynch, Patrick, Parry, Susan, Jenkins, Mark A., Gallinger, Steven, Holter, Spring, Aronson, Melyssa, Newcomb, Polly A., Burnett, Terrilea, Le Marchand, Loïc, Pichurin, Pavel, Hampel, Heather, Terdiman, Jonathan P., Lu, Karen H., Thibodeau, Stephen, Lindor, Noralane M.
Izdano u Genet Med (2015)

Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial

od Aung, Kyaw L., Fischer, Sandra E., Denroche, Robert E., Jang, Gun-Ho, Dodd, Anna, Creighton, Sean, Southwood, Bernadette, Liang, Sheng-Ben, Chadwick, Dianne, Zhang, Amy, O’Kane, Grainne M., Albaba, Hamzeh, Moura, Shari, Grant, Robert C., Miller, Jessica K., Mbabaali, Faridah, Pasternack, Danielle, Lungu, Ilinca M., Bartlett, John M.S., Ghai, Sangeet, Lemire, Mathieu, Holter, Spring, Connor, Ashton A., Moffitt, Richard A., Yeh, Jen Jen, Timms, Lee, Krzyzanowski, Paul M., Dhani, Neesha, Hedley, David, Notta, Faiyaz, Wilson, Julie M., Moore, Malcolm J., Gallinger, Steven, Knox, Jennifer J.
Izdano u Clin Cancer Res (2017)